Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hytönen J[au]:

Lyme Borreliosis in Finland, 1995-2014. Sajanti E et al. Emerg Infect Dis. (2017)

Relapsing fever. Hytönen J et al. Duodecim. (2016)

Biodegradable coronary scaffolds: their future and clinical and technological challenges. Hytönen JP et al. Cardiovasc Res. (2018)

Search results

Items: 1 to 50 of 55

1.

Cerebrospinal Fluid Pleocytosis and Elevated C-X-C Motif Chemokine Ligand 13 Value Predict Lyme Borreliosis in Children With Facial Palsy.

Pöyhönen H, Lähdesmäki T, Hytönen J, Peltola V.

Pediatr Infect Dis J. 2019 Dec;38(12):1195-1198. doi: 10.1097/INF.0000000000002475.

PMID:
31634297
2.

Seroprevalence of Lyme borreliosis in Finland 50 years ago.

Cuellar J, Dub T, Sane J, Hytönen J.

Clin Microbiol Infect. 2019 Oct 14. pii: S1198-743X(19)30530-0. doi: 10.1016/j.cmi.2019.10.003. [Epub ahead of print]

3.

NMR metabolome of Borrelia burgdorferi in vitro and in vivo in mice.

Glader O, Puljula E, Jokioja J, Karonen M, Sinkkonen J, Hytönen J.

Sci Rep. 2019 May 29;9(1):8049. doi: 10.1038/s41598-019-44540-5.

4.

Serial Optical Coherence Tomography at Baseline, 7 Days, and 1, 3, 6 and 12 Months After Bioresorbable Scaffold Implantation in a Growing Porcine Model.

Asano T, Hytönen J, Chichareon P, Taavitsainen J, Kogame N, Katagiri Y, Miyazaki Y, Takahashi K, Modolo R, Komiyama H, Tenekecioglu E, Sotomi Y, Wykrzykowska JJ, Piek JJ, Martin J, Baumbach A, Mathur A, Onuma Y, Ylä-Herttuala S, Serruys PW.

Circ J. 2019 Feb 25;83(3):556-566. doi: 10.1253/circj.CJ-18-0855. Epub 2019 Jan 31.

5.

Borrelia burgdorferi Infection in Biglycan Knockout Mice.

Cuellar J, Pietikäinen A, Glader O, Liljenbäck H, Söderström M, Hurme S, Salo J, Hytönen J.

J Infect Dis. 2019 Jun 5;220(1):116-126. doi: 10.1093/infdis/jiz050.

PMID:
30698707
6.

Predicting the ligand-binding properties of Borrelia burgdorferi s.s. Bmp proteins in light of the conserved features of related Borrelia proteins.

Åstrand M, Cuellar J, Hytönen J, Salminen TA.

J Theor Biol. 2019 Feb 7;462:97-108. doi: 10.1016/j.jtbi.2018.11.004. Epub 2018 Nov 9.

7.

Tick-borne pathogens in Finland: comparison of Ixodes ricinus and I. persulcatus in sympatric and parapatric areas.

Laaksonen M, Klemola T, Feuth E, Sormunen JJ, Puisto A, Mäkelä S, Penttinen R, Ruohomäki K, Hänninen J, Sääksjärvi IE, Vuorinen I, Sprong H, Hytönen J, Vesterinen EJ.

Parasit Vectors. 2018 Oct 24;11(1):556. doi: 10.1186/s13071-018-3131-y.

8.

Borrelia afzelii alters reproductive success in a rodent host.

Cayol C, Giermek A, Gomez-Chamorro A, Hytönen J, Kallio ER, Mappes T, Salo J, Voordouw MJ, Koskela E.

Proc Biol Sci. 2018 Aug 1;285(1884). pii: 20181056. doi: 10.1098/rspb.2018.1056.

9.

Local adventitial anti-angiogenic gene therapy reduces growth of vasa-vasorum and in-stent restenosis in WHHL rabbits.

Hytönen JP, Taavitsainen J, Laitinen JTT, Partanen A, Alitalo K, Leppänen O, Ylä-Herttuala S.

J Mol Cell Cardiol. 2018 Aug;121:145-154. doi: 10.1016/j.yjmcc.2018.07.007. Epub 2018 Jul 9.

PMID:
30003882
10.

Aluminum fluoride-18 labeled folate enables in vivo detection of atherosclerotic plaque inflammation by positron emission tomography.

Silvola JMU, Li XG, Virta J, Marjamäki P, Liljenbäck H, Hytönen JP, Tarkia M, Saunavaara V, Hurme S, Palani S, Hakovirta H, Ylä-Herttuala S, Saukko P, Chen Q, Low PS, Knuuti J, Saraste A, Roivainen A.

Sci Rep. 2018 Jun 26;8(1):9720. doi: 10.1038/s41598-018-27618-4.

11.

Biodegradable coronary scaffolds: their future and clinical and technological challenges.

Hytönen JP, Taavitsainen J, Tarvainen S, Ylä-Herttuala S.

Cardiovasc Res. 2018 Jul 1;114(8):1063-1072. doi: 10.1093/cvr/cvy097. Review.

PMID:
29718125
12.

Point-of-care testing for CXCL13 in Lyme neuroborreliosis.

Pietikäinen A, Oksi J, Hytönen J.

Diagn Microbiol Infect Dis. 2018 Jul;91(3):226-228. doi: 10.1016/j.diagmicrobio.2018.02.013. Epub 2018 Feb 23.

PMID:
29567125
13.

Magnetically Coated Bioabsorbable Stents for Renormalization of Arterial Vessel Walls after Stent Implantation.

Lee JS, Han P, Song E, Kim D, Lee H, Labowsky M, Taavitsainen J, Ylä-Herttuala S, Hytönen J, Gülcher M, Perampaladas K, Sinusas AJ, Martin J, Mathur A, Fahmy TM.

Nano Lett. 2018 Jan 10;18(1):272-281. doi: 10.1021/acs.nanolett.7b04096. Epub 2017 Dec 28.

PMID:
29268605
14.

Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice.

Siitonen R, Pietikäinen A, Liljenbäck H, Käkelä M, Söderström M, Jalkanen S, Hytönen J, Roivainen A.

Arthritis Res Ther. 2017 Nov 22;19(1):254. doi: 10.1186/s13075-017-1460-4.

15.

Population-based Borrelia burgdorferi sensu lato seroprevalence and associated risk factors in Finland.

van Beek J, Sajanti E, Helve O, Ollgren J, Virtanen MJ, Rissanen H, Lyytikäinen O, Hytönen J, Sane J.

Ticks Tick Borne Dis. 2018 Feb;9(2):275-280. doi: 10.1016/j.ttbdis.2017.10.018. Epub 2017 Nov 11.

PMID:
29153461
16.

Cerebral vasculitis and intracranial multiple aneurysms in a child with Lyme neuroborreliosis.

Kortela E, Hytönen J, Numminen J, Overmyer M, Saxen H, Oksi J.

JMM Case Rep. 2017 Apr 21;4(4):e005090. doi: 10.1099/jmmcr.0.005090. eCollection 2017 Apr.

17.

Lyme Borreliosis in Finland, 1995-2014.

Sajanti E, Virtanen M, Helve O, Kuusi M, Lyytikäinen O, Hytönen J, Sane J.

Emerg Infect Dis. 2017 Aug;23(8):1282-1288. doi: 10.3201/eid2308.161273.

18.

In vivo imaging of Lyme arthritis in mice by [18F]fluorodeoxyglucose positron emission tomography/computed tomography.

Pietikäinen A, Siitonen R, Liljenbäck H, Eskola O, Söderström M, Roivainen A, Hytönen J.

Scand J Rheumatol. 2018 Jan;47(1):37-47. doi: 10.1080/03009742.2017.1287306. Epub 2017 Jun 26.

PMID:
28649922
19.

Crowdsourcing-based nationwide tick collection reveals the distribution of Ixodes ricinus and I. persulcatus and associated pathogens in Finland.

Laaksonen M, Sajanti E, Sormunen JJ, Penttinen R, Hänninen J, Ruohomäki K, Sääksjärvi I, Vesterinen EJ, Vuorinen I, Hytönen J, Klemola T.

Emerg Microbes Infect. 2017 May 10;6(5):e31. doi: 10.1038/emi.2017.17.

20.

Aetiology of febrile pharyngitis in children: Potential of myxovirus resistance protein A (MxA) as a biomarker of viral infection.

Ivaska L, Niemelä J, Lempainen J, Österback R, Waris M, Vuorinen T, Hytönen J, Rantakokko-Jalava K, Peltola V.

J Infect. 2017 Apr;74(4):385-392. doi: 10.1016/j.jinf.2017.01.002. Epub 2017 Jan 7.

PMID:
28077283
21.

Louse-borne relapsing fever in Finland in two asylum seekers from Somalia.

Hytönen J, Khawaja T, Grönroos JO, Jalava A, Meri S, Oksi J.

APMIS. 2017 Jan;125(1):59-62. doi: 10.1111/apm.12635. Epub 2016 Nov 16.

PMID:
27859692
22.

Cerebrospinal fluid cytokines in Lyme neuroborreliosis.

Pietikäinen A, Maksimow M, Kauko T, Hurme S, Salmi M, Hytönen J.

J Neuroinflammation. 2016 Oct 18;13(1):273.

23.

[Did you know this about the diseases spread by ticks?].

Hytönen J.

Duodecim. 2016;132(13-14):1261-9. Finnish.

PMID:
27522835
24.

Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.

Hytönen J, Leppänen O, Braesen JH, Schunck WH, Mueller D, Jung F, Mrowietz C, Jastroch M, von Bergwelt-Baildon M, Kappert K, Heuser A, Drenckhahn JD, Pieske B, Thierfelder L, Ylä-Herttuala S, Blaschke F.

Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1534-48. doi: 10.1161/ATVBAHA.115.306962. Epub 2016 Jun 9.

PMID:
27283742
25.

Flow-Tolerant Adhesion of a Bacterial Pathogen to Human Endothelial Cells Through Interaction With Biglycan.

Salo J, Pietikäinen A, Söderström M, Auvinen K, Salmi M, Ebady R, Moriarty TJ, Viljanen MK, Hytönen J.

J Infect Dis. 2016 May 15;213(10):1623-31. doi: 10.1093/infdis/jiw003. Epub 2016 Jan 5.

PMID:
26740275
26.

Relapsing fever.

Hytönen J, Khawaja T, Grönroos JO, Jalava A, Meri S, Oksi J.

Duodecim. 2016;132(21):1952-6. Review.

PMID:
29190046
27.

Array-in-well platform-based multiplex assay for the simultaneous detection of anti-HIV- and treponemal-antibodies, and Hepatitis B surface antigen.

Talha SM, Saviranta P, Hattara L, Vuorinen T, Hytönen J, Khanna N, Pettersson K.

J Immunol Methods. 2016 Feb;429:21-7. doi: 10.1016/j.jim.2015.12.007. Epub 2015 Dec 19.

PMID:
26711310
28.

Assessing the abundance, seasonal questing activity, and Borrelia and tick-borne encephalitis virus (TBEV) prevalence of Ixodes ricinus ticks in a Lyme borreliosis endemic area in Southwest Finland.

Sormunen JJ, Klemola T, Vesterinen EJ, Vuorinen I, Hytönen J, Hänninen J, Ruohomäki K, Sääksjärvi IE, Tonteri E, Penttinen R.

Ticks Tick Borne Dis. 2016 Feb;7(1):208-215. doi: 10.1016/j.ttbdis.2015.10.011. Epub 2015 Oct 24.

PMID:
26548608
29.

Incidence and seroprevalence of tularaemia in Finland, 1995 to 2013: regional epidemics with cyclic pattern.

Rossow H, Ollgren J, Hytonen J, Rissanen H, Huitu O, Henttonen H, Kuusi M, Vapalahti O.

Euro Surveill. 2015 Aug 20;20(33):21209.

30.

Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice.

Salo J, Jaatinen A, Söderström M, Viljanen MK, Hytönen J.

PLoS One. 2015 Mar 27;10(3):e0121512. doi: 10.1371/journal.pone.0121512. eCollection 2015.

31.

Lyme Borreliosis and Deficient Mannose-Binding Lectin Pathway of Complement.

Sajanti EM, Gröndahl-Yli-Hannuksela K, Kauko T, He Q, Hytönen J.

J Immunol. 2015 Jan 1;194(1):358-363. doi: 10.4049/jimmunol.1402128. Epub 2014 Nov 21.

32.

Ultrasound imaging with bolus delivered contrast agent for the detection of angiogenesis and blood flow irregularities.

Korpisalo P, Hytönen JP, Laitinen JT, Närväinen J, Rissanen TT, Gröhn OH, Ylä-Herttuala S.

Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1226-32. doi: 10.1152/ajpheart.00315.2013. Epub 2014 Aug 22.

33.

CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.

Hytönen J, Kortela E, Waris M, Puustinen J, Salo J, Oksi J.

J Neuroinflammation. 2014 Jun 11;11:103. doi: 10.1186/1742-2094-11-103.

34.

Europium nanoparticle-based high performing immunoassay for the screening of treponemal antibodies.

Talha SM, Hytönen J, Westhorpe A, Kumar S, Khanna N, Pettersson K.

PLoS One. 2013 Dec 26;8(12):e84050. doi: 10.1371/journal.pone.0084050. eCollection 2013.

35.

Decorin binding by DbpA and B of Borrelia garinii, Borrelia afzelii, and Borrelia burgdorferi sensu Stricto.

Salo J, Loimaranta V, Lahdenne P, Viljanen MK, Hytönen J.

J Infect Dis. 2011 Jul 1;204(1):65-73. doi: 10.1093/infdis/jir207.

36.

Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.

Korpisalo P, Hytönen JP, Laitinen JT, Laidinen S, Parviainen H, Karvinen H, Siponen J, Marjomäki V, Vajanto I, Rissanen TT, Ylä-Herttuala S.

Eur Heart J. 2011 Jul;32(13):1664-72. doi: 10.1093/eurheartj/ehq433. Epub 2010 Dec 7.

PMID:
21138938
37.

Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment.

Yrjänäinen H, Hytönen J, Hartiala P, Oksi J, Viljanen MK.

APMIS. 2010 Sep 1;118(9):665-73. doi: 10.1111/j.1600-0463.2010.02615.x.

PMID:
20718718
38.

TLR2 utilization of Borrelia does not induce p38- and IFN-beta autocrine loop-dependent expression of CD38, resulting in poor migration and weak IL-12 secretion of dendritic cells.

Hartiala P, Hytönen J, Yrjänäinen H, Honkinen M, Terho P, Söderström M, Penttinen MA, Viljanen MK.

J Immunol. 2010 May 15;184(10):5732-42. doi: 10.4049/jimmunol.0803944. Epub 2010 Apr 14.

39.

Disordered lymphoid purine metabolism contributes to the pathogenesis of persistent Borrelia garinii infection in mice.

Yegutkin GG, Hytönen J, Samburski SS, Yrjänäinen H, Jalkanen S, Viljanen MK.

J Immunol. 2010 May 1;184(9):5112-20. doi: 10.4049/jimmunol.0902760. Epub 2010 Mar 31.

40.

Leucine-rich repeats of bacterial surface proteins serve as common pattern recognition motifs of human scavenger receptor gp340.

Loimaranta V, Hytönen J, Pulliainen AT, Sharma A, Tenovuo J, Strömberg N, Finne J.

J Biol Chem. 2009 Jul 10;284(28):18614-23. doi: 10.1074/jbc.M900581200. Epub 2009 May 22.

41.

Bordetella pertussis isolates in Finland: serotype and fimbrial expression.

Heikkinen E, Xing DK, Olander RM, Hytönen J, Viljanen MK, Mertsola J, He Q.

BMC Microbiol. 2008 Sep 25;8:162. doi: 10.1186/1471-2180-8-162.

42.

Borreliosis: recent research, diagnosis, and management.

Hytönen J, Hartiala P, Oksi J, Viljanen MK.

Scand J Rheumatol. 2008 May-Jun;37(3):161-72. doi: 10.1080/03009740801978897. Review.

PMID:
18465449
43.

Deficiency of the Rgg regulator promotes H2O2 resistance, AhpCF-mediated H2O2 decomposition, and virulence in Streptococcus pyogenes.

Pulliainen AT, Hytönen J, Haataja S, Finne J.

J Bacteriol. 2008 May;190(9):3225-35. doi: 10.1128/JB.01843-07. Epub 2008 Feb 29.

44.

Borrelia burgdorferi inhibits human neutrophil functions.

Hartiala P, Hytönen J, Suhonen J, Leppäranta O, Tuominen-Gustafsson H, Viljanen MK.

Microbes Infect. 2008 Jan;10(1):60-8. Epub 2007 Oct 18.

PMID:
18068388
45.

Transcriptional response of human dendritic cells to Borrelia garinii--defective CD38 and CCR7 expression detected.

Hartiala P, Hytönen J, Pelkonen J, Kimppa K, West A, Penttinen MA, Suhonen J, Lahesmaa R, Viljanen MK.

J Leukoc Biol. 2007 Jul;82(1):33-43. Epub 2007 Apr 17.

PMID:
17440035
46.

Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.

Yrjänäinen H, Hytönen J, Song XY, Oksi J, Hartiala K, Viljanen MK.

J Infect Dis. 2007 May 15;195(10):1489-96. Epub 2007 Apr 6.

PMID:
17436229
47.

Use of CFSE staining of borreliae in studies on the interaction between borreliae and human neutrophils.

Tuominen-Gustafsson H, Penttinen M, Hytönen J, Viljanen MK.

BMC Microbiol. 2006 Oct 18;6:92.

48.

Persistent joint swelling and Borrelia-specific antibodies in Borrelia garinii-infected mice after eradication of vegetative spirochetes with antibiotic treatment.

Yrjänäinen H, Hytönen J, Söderström KO, Oksi J, Hartiala K, Viljanen MK.

Microbes Infect. 2006 Jul;8(8):2044-51. Epub 2006 May 30.

PMID:
16797205
50.

Fluid- or surface-phase human salivary scavenger protein gp340 exposes different bacterial recognition properties.

Loimaranta V, Jakubovics NS, Hytönen J, Finne J, Jenkinson HF, Strömberg N.

Infect Immun. 2005 Apr;73(4):2245-52.

Supplemental Content

Loading ...
Support Center